Weize Xu

Papers

Total Citations

H-Index

About

Weize Xu is a radiation oncologist whose research focuses on advancing stereotactic radiation therapy for brain metastases, particularly through hypofractionated regimens. Xu’s most cited work, "Outcomes With Hypofractionated Stereotactic Radiation Therapy (hfSRT) in Patients With Intact Brain Metastases and Postoperative Surgical Cavities" (2014), provides critical clinical evidence on the efficacy and safety of delivering higher-dose-per-fraction radiation to both intact tumors and post-surgical cavities. This study helps refine treatment paradigms for patients with limited intracranial disease, offering an alternative to whole-brain radiotherapy that reduces neurocognitive toxicity while maintaining local control. Though early in citation impact, Xu’s contributions address a pressing need in neuro-oncology: balancing tumor control with quality of life. By systematically evaluating outcomes across distinct clinical scenarios—intact metastases versus surgical cavities—Xu’s work informs personalized treatment planning and underscores the importance of dose fractionation in stereotactic radiosurgery. This research is foundational for clinicians seeking to optimize radiation delivery in complex brain metastasis cases, and it positions Xu as a careful investigator in the evolving field of CNS radiation oncology.